Zebra Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Zebra Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,144	Closed	-$415K	–	480
2019 Q2	$415K	Buy	5,144 +383	+8%	+$26.9K	0.22%	145
2019 Q1	$318K	Hold	4,761	–	–	0.17%	257
2018 Q4	$354K	Buy	4,761 +16	+0.3%	+$1.32K	0.22%	207
2018 Q3	$437K	Sell	4,745 -2,748	-37%	-$262K	0.2%	227
2018 Q2	$737K	Sell	7,493 -5,859	-44%	-$655K	0.32%	168
2018 Q1	$1.49M	Buy	13,352 +8,767	+191%	+$983K	0.53%	24
2017 Q4	$472K	Buy	4,585 +341	+8%	+$34K	0.16%	264
2017 Q3	$400K	Buy	+4,244	New	+$335K	0.13%	222
2016 Q4	–	Sell	-3,166	Closed	-$247K	–	299
2016 Q3	$247K	Hold	3,166	–	–	0.08%	258
2016 Q2	$218K	Sell	3,166 -10,265	-76%	-$708K	0.08%	257
2016 Q1	$958K	Buy	13,431 +2,254	+20%	+$141K	0.38%	122
2015 Q4	$695K	Buy	11,177 +768	+7%	+$46.9K	0.39%	122
2015 Q3	$590K	Buy	+10,409	New	+$551K	0.36%	134

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Zebra Capital Management's CMD Position: Q3 2019 in Review

Zebra Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 5,144 shares — an estimated $415K sold.

Zebra Capital Management first reported a position in CMD in Q3 2015 and held it in 13 quarters. The position peaked at $1.49M in Q1 2018. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Zebra Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
Zebra Capital Management sold 5,144 Cantel Medical Corporation shares in Q3 2019, an estimated $415K.
Zebra Capital Management first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 13 quarters.
Zebra Capital Management's Cantel Medical Corporation position peaked at $1.49M in Q1 2018.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Zebra Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.